Is this you? Create Your Porfile
Avatar

Satoshi Yanagihara

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Satoshi Yanagihara is active.

Explore More

Publication

Featured researches published by Satoshi Yanagihara.

Archive | 2002

4-Oxoquinolizine antimicrobial having 2-pyridone skeleton as partial structure

Ryoichi Fukumoto; Hiroyuki Kusakabe; Chong Chu; Hiroaki Kimura; Satoshi Yanagihara; Masatoshi Kato; Chisato Hirosawa; Seiji Ishiduka; Fusae Shizume

International Immunopharmacology | 2004

Effect of a topical steroid on gene expressions for chemokines in mice with contact hypersensitivity

Gaku Mitsui; Takeo Hirano; Yoshimi Niwano; Kazutaka Mitsui; Osamu Ohara; Satoshi Yanagihara; Masatoshi Kato

Archive | 2000

4-oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure

Chong Chu; Ryoichi Fukumoto; Chisato Hirosawa; Seiji Ishiduka; Masatoshi Kato; Hiroaki Kimura; Hiroyuki Kusakabe; Fusae Shizume; Satoshi Yanagihara

Archive | 2004

4-Oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure

Ryoichi Fukumoto; Yoshimi Niwano; Hiroyuki Kusakabe; Chong Chu; Hiroaki Kimura; Koh Nagasawa; Satoshi Yanagihara; Chisato Hirosawa; Seiji Ishiduka

Archive | 2004

Antifungal agent for external application

Seiji Ishizuka; Masahide Katayama; Toshito Shimizu; Tomohiro Tada; Satoshi Yanagihara; 知広 多田; 智 柳原; 俊人 清水; 雅英 片山; 誠治 石塚

Archive | 2004

Antifungal agent for topical use

Seiji Ishiduka; Tomohiro Tada; Masahide Katayama; Satoshi Yanagihara; Toshihito Shimizu

Archive | 2003

Antifungal agents for external use

Seiji Ishiduka; Tomohiro Tada; Masahide Katayama; Satoshi Yanagihara; Toshihito Shimizu

Archive | 2009

PHARMACEUTICAL COMPOSITIONS CONTAINING 2-PYRIDONE DERIVATIVES AS EFFECTIVE COMPONENTS

Masatoshi Kato; Hiroyuki Kusakabe; Satoshi Yanagihara; Hidenori Akizawa; Yushi Tamoto

Archive | 2006

Pharmaceutical composition comprising 2-pyridone derivative as active ingredient

Masatoshi Kato; Hiroyuki Kusakabe; Satoshi Yanagihara; Hidenori Akizawa; Yuji Tamoto

Archive | 2006

Composition pharmaceutique comprenant un dérivé de 2-pyridone comme ingrédient actif

Masatoshi Kato; Hiroyuki Kusakabe; Satoshi Yanagihara; Hidenori Akizawa; Yuji Tamoto

Explore More

Collaboration

Dive into the Satoshi Yanagihara's collaboration.

Top Co-Authors
Avatar

Masatoshi Kato

Tohoku University

View shared research outputs
Top Co-Authors
Avatar

Yoshimi Niwano

Tohoku University

View shared research outputs
Top Co-Authors
Avatar

Osamu Ohara

Chiba University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge